Clinical Trial Update: Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completed Phase 1/2 testing of autologous T cell immunotherapy for Chronic Lymphocytic Leukemia conducted by Xcyte Therapies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Autologous T Cell Immunotherapy

Snippet

Sponsor: Xcyte Therapies | Conditions: Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: COMPLETED